Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yacyshyn

Showing results (11-20 of 178) with videos related to

Pageof 18
Sort By:
Scandinavian Journal of Immunology|April 1, 1996
Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytesB R Yacyshyn, M B Bowen-Yacyshyn, L M Pilarski
Current Therapeutic Research, Clinical and Experimental|April 4, 2022
Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapyMary Beth Yacyshyn, James Collins, Michelle Chua, et al.
Immunology and Cell Biology|August 1, 1993
Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitisB R Yacyshyn
Methods in Molecular Medicine|September 18, 2004
Antisense oligonucleotide treatment of inflammatory bowel diseasesBruce R Yacyshyn
Lancet (London, England)|September 5, 1998
Drug treatment for Crohn's diseaseB R Yacyshyn
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
New biotechnological therapies for Crohn's disease: where are we now?B R Yacyshyn
The Journal of Rheumatology|June 15, 2024
Montelukast as a Rescue and Premedication for Rituximab Infusion ReactionsLindsay Amatto, Elaine Yacyshyn
Cardiology in Review|January 16, 2002
The ten most commonly asked questions about management of peripheral arterial diseaseIan McPhail, Vincent Yacyshyn
Bulletin on the Rheumatic Diseases|March 24, 1998
Case management study: osteoporotic vertebral compression fractureE Yacyshyn, J M Evans
JMIR Formative Research|December 12, 2023
Thoughts and Experiences of Behçet Disease From Participants on a Reddit Subforum: Qualitative Online Community AnalysisJenny Xiaoyu Li, Elaine Yacyshyn
Pageof 18

Showing results (11-20 of 178) with videos related to

Sort By:
Pageof 18
Scandinavian Journal of Immunology|April 1, 1996
Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytesB R Yacyshyn, M B Bowen-Yacyshyn, L M Pilarski
Current Therapeutic Research, Clinical and Experimental|April 4, 2022
Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapyMary Beth Yacyshyn, James Collins, Michelle Chua, et al.
Immunology and Cell Biology|August 1, 1993
Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitisB R Yacyshyn
Methods in Molecular Medicine|September 18, 2004
Antisense oligonucleotide treatment of inflammatory bowel diseasesBruce R Yacyshyn
Lancet (London, England)|September 5, 1998
Drug treatment for Crohn's diseaseB R Yacyshyn
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
New biotechnological therapies for Crohn's disease: where are we now?B R Yacyshyn
The Journal of Rheumatology|June 15, 2024
Montelukast as a Rescue and Premedication for Rituximab Infusion ReactionsLindsay Amatto, Elaine Yacyshyn
Cardiology in Review|January 16, 2002
The ten most commonly asked questions about management of peripheral arterial diseaseIan McPhail, Vincent Yacyshyn
Bulletin on the Rheumatic Diseases|March 24, 1998
Case management study: osteoporotic vertebral compression fractureE Yacyshyn, J M Evans
JMIR Formative Research|December 12, 2023
Thoughts and Experiences of Behçet Disease From Participants on a Reddit Subforum: Qualitative Online Community AnalysisJenny Xiaoyu Li, Elaine Yacyshyn
Pageof 18